{"content":"<li class=\"n-box-item date-title\" data-end=\"1475035199\" data-start=\"1474948800\" data-txt=\"Sunday, December 22, 2019\">Tuesday, September 27, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3211175\" data-ts=\"1475020331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211175-harmonicplus-7_3-on-warrant-deal-comcast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harmonic +7.3% on warrant deal with Comcast</a></h4><ul>   <li>Shares of Harmonic (<a href=\"https://seekingalpha.com/symbol/HLIT\" title=\"Harmonic Inc.\">HLIT</a> <font color=\"green\">+1.3%</font>) are <font color=\"green\">up 7.3%</font> after hours following a warrant agreement with Comcast (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a>) giving the cable giant the right to buy shares.</li>    <li>That right's based on Harmonic's ability to hit specific sales and deployment milestones, the company says -- a \"significant validation of our new product investment strategy,\" says CEO Patrick Harshman.</li>    <li>Harmonic will hold a <a href=\"https://www.harmonicinc.com/news-events/events/\" target=\"_blank\">conference call</a> and discuss financial info at 9 a.m. ET tomorrow.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211175\" data-linked=\"Harmonic +7.3% on warrant deal with Comcast\" data-tweet=\"$CMCSA $CMCSA $HLIT - Harmonic +7.3% on warrant deal with Comcast https://seekingalpha.com/news/3211175-harmonicplus-7_3-on-warrant-deal-comcast?source=tweet\" data-url=\"https://seekingalpha.com/news/3211175-harmonicplus-7_3-on-warrant-deal-comcast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211170\" data-ts=\"1475015511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMCX\" target=\"_blank\">AMCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211170-amc-networks-firms-up-international-programming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMC Networks firms up international programming</a></h4><ul>   <li>AMC Networks (<a href=\"https://seekingalpha.com/symbol/AMCX\" title=\"AMC Networks Inc.\">AMCX</a> <font color=\"red\">-2%</font>) has set up its new team to <a href=\"http://www.broadcastingcable.com/news/programming/amc-names-international-programming-team/159944\" target=\"_blank\">manage international programming</a>.</li>    <li>Kristin Jones, senior VP of international programming for AMC, is in charge of managing programming and co-productions for AMC TV and SundanceTV. The company's adding Chris Loveall as VP to help with development and acquisitions.</li>    <li>Jones, who help nab shows including The Night Manager and Humans for AMC, will continue to report to programming president Joel Stillerman.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211170\" data-linked=\"AMC Networks firms up international programming\" data-tweet=\"$AMCX - AMC Networks firms up international programming https://seekingalpha.com/news/3211170-amc-networks-firms-up-international-programming?source=tweet\" data-url=\"https://seekingalpha.com/news/3211170-amc-networks-firms-up-international-programming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211169\" data-ts=\"1475015185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEED\" target=\"_blank\">SEED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211169-origin-agritech-to-sell-seed-production-and-distribution-business-for-60m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Origin Agritech to sell seed production and distribution business for $60M</a></h4><ul>     <li>Agricultural biotech company Origin Agritech (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SEED\" title=\"Origin Agritech Limited\">SEED</a>) <font color=\"green\">+37.3%</font> AH after agreeing to sell its China-based commercial corn seed production and distribution business to Beijing Shihui Agricultural Development for ~$60M.</li>     <li>As part of the deal, Origin will receive a royalty stream for the present and future product portfolio and  a technology access fee for research and development.</li>     <li>Origin says it will retain its corn breeding and biotech R&amp;D capabilities.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211169\" data-linked=\"Origin Agritech to sell seed production and distribution business for $60M\" data-tweet=\"$SEED - Origin Agritech to sell seed production and distribution business for $60M https://seekingalpha.com/news/3211169-origin-agritech-to-sell-seed-production-and-distribution-business-for-60m?source=tweet\" data-url=\"https://seekingalpha.com/news/3211169-origin-agritech-to-sell-seed-production-and-distribution-business-for-60m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211168\" data-ts=\"1475014210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GXP\" target=\"_blank\">GXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211168-great-plains-to-launch-concurrent-stock-offerings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Plains to launch concurrent stock offerings</a></h4><ul>     <li>Great Plains Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/GXP\" title=\"Great Plains Energy Inc.\">GXP</a>) <font color=\"red\">-1.7%</font>Â AH after announcing concurrent public offerings of 52.6M common shares and 15M depositary shares representing interests in mandatory convertible preferred stock.</li>\n<li>GXP also grants underwriter options to purchase up to an additional 7.89M common shares and up to an additional 2.25Ml depositary shares.</li>\n<li>GXP says it plans to use the proceeds from the offerings to help finance its <a href=\"https://seekingalpha.com/news/3186272-great-plains-energy-buy-westar-energy-8_6b\" target=\"_blank\">proposed acquisition</a>  of Westar Energy.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211168\" data-linked=\"Great Plains to launch concurrent stock offerings\" data-tweet=\"$GXP - Great Plains to launch concurrent stock offerings https://seekingalpha.com/news/3211168-great-plains-to-launch-concurrent-stock-offerings?source=tweet\" data-url=\"https://seekingalpha.com/news/3211168-great-plains-to-launch-concurrent-stock-offerings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211163\" data-ts=\"1475012146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211163-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='green'>+32.2%</font>. <a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a> <font color='green'>+5.8%</font>. <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='green'>+4.6%</font>. <a href='https://seekingalpha.com/symbol/CTAS' title='Cintas Corporation'>CTAS</a> <font color='green'>+4.0%</font>. TVIA <font color='green'>+3.9%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a> <font color='red'>-24.4%</font>. SCSS <font color='red'>-9.4%</font>. <a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color='red'>-6.4%</font>. <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-4.9%</font>. <a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='red'>-4.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211163\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$SEED $COTY $PIR - After Hours Gainers / Losers https://seekingalpha.com/news/3211163-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3211163-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211162\" data-ts=\"1475011683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COTY\" target=\"_blank\">COTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211162-coty-set-to-replace-diamond-offshore-in-s-and-p-500minus-1_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coty set to replace Diamond Offshore in S&amp;P 500; DO -1.3%</a></h4><ul>   <li>Coty (<a href=\"https://seekingalpha.com/symbol/COTY\" title=\"Coty Inc.\">COTY</a> <font color=\"green\">+0.3%</font>) is <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/409359_2coty5do4oth.pdf?force_download=true\" target=\"_blank\">heading to the S&amp;P 500</a>, replacing Diamond Offshore Drilling (<a href=\"https://seekingalpha.com/symbol/DO\" title=\"Diamond Offshore Drilling Inc.\">DO</a> <font color=\"red\">-0.4%</font>) in that index. Diamond Offshore is <font color=\"red\">off 1.3%</font> after hours, while <a href=\"https://seekingalpha.com/symbol/COTY\" title=\"Coty Inc.\">COTY</a> is <font color=\"green\">up 0.4%</font>.</li>    <li>Diamond Offshore will move to the S&amp;P MidCap 400, replacing Polycom (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PLCM\" title=\"Polycom, Inc.\">PLCM</a>), which has been acquired by Siris Capital Group. The contract driller was ranked at the bottom of the 500 and now has a market cap more reflective of a mid-cap, S&amp;P Dow Jones Indices says.</li>    <li>The moves are effective after the close on Friday.</li>    <li>Meanwhile, Tile Shop Holdings (<a href=\"https://seekingalpha.com/symbol/TTS\" title=\"Tile Shop Holdings, Inc.\">TTS</a> <font color=\"red\">-0.3%</font>) is replacing Epiq Systems (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EPIQ\" title=\"EPIQ Systems, Inc.\">EPIQ</a>) in the SmallCap 600, as Omers Private Equity is acquiring Epiq in a deal expected to be completed soon.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211162\" data-linked=\"Coty set to replace Diamond Offshore in S&amp;P 500; DO -1.3%\" data-tweet=\"$COTY $COTY $PLCM - Coty set to replace Diamond Offshore in S&amp;P 500; DO -1.3% https://seekingalpha.com/news/3211162-coty-set-to-replace-diamond-offshore-in-s-and-p-500minus-1_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3211162-coty-set-to-replace-diamond-offshore-in-s-and-p-500minus-1_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211154\" data-ts=\"1475009925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211154-array-biopharma-launches-100m-equity-offering-shares-off-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array BioPharma launches $100M equity offering; shares off 4% after hours</a></h4><ul>\n<li>Array BioPharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARRY\" title=\"Array BioPharma Inc.\">ARRY</a>) easesÂ <font color=\"red\">4%</font>Â after hours on robust volume in response to its announcement that it has initiated a $100M public offering of common stock. Price, volume and terms have yet to be announced.</li>\n<li>\n<strong>Update</strong>: On September 27, the company announced that it increased the size of its equity offering 15% to $115M,Â specifically 18.4M shares of common stock at $6.25.Underwriters over-allotment is an additional 2.76M shares. Closing date is October 3.</li>\n<li>Net proceeds will fund R&amp;D, the build-out of commercial capability, working capital and general corporate purposes. TheÂ close price on September 27 was $6.59.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211154\" data-linked=\"Array BioPharma launches $100M equity offering; shares off 4% after hours\" data-tweet=\"$ARRY - Array BioPharma launches $100M equity offering; shares off 4% after hours https://seekingalpha.com/news/3211154-array-biopharma-launches-100m-equity-offering-shares-off-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3211154-array-biopharma-launches-100m-equity-offering-shares-off-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211153\" data-ts=\"1475009681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211153-alphabet-active-after-hours-on-wedbush-securities-downgrade-to-underperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alphabet active after hours on Wedbush Securities downgrade to Underperform</a></h4><ul>\n<li>AlphabetÂ Class CÂ (<a href=\"https://seekingalpha.com/symbol/GOOG/focus\" target=\"_blank\">GOOG</a>)Â shares areÂ <font color=\"red\">lower by 0.7%</font>Â while Class AÂ (<a href=\"https://seekingalpha.com/symbol/GOOGL/focus\" target=\"_blank\">GOOGL</a>) shares areÂ <font color=\"red\">down 0.83%</font>Â on the <a href=\"http://www.streetinsider.com/Downgrades/Wedbush+Downgrades+Alphabet+%28GOOGL%29+to+Underperform/12076245.html\" target=\"_blank\">report</a>.</li>\n<li>Firm previously retained a Neutral rating.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211153\" data-linked=\"Alphabet active after hours on Wedbush Securities downgrade to Underperform\" data-tweet=\"$GOOG $GOOG $GOOGL - Alphabet active after hours on Wedbush Securities downgrade to Underperform https://seekingalpha.com/news/3211153-alphabet-active-after-hours-on-wedbush-securities-downgrade-to-underperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3211153-alphabet-active-after-hours-on-wedbush-securities-downgrade-to-underperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211152\" data-ts=\"1475009675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211152-select-comfort-stung-tempur-sealy-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Comfort stung by Tempur Sealy warning</a></h4><ul><li>Tempur Sealy isÂ <font color=\"red\">lower by 27%</font>Â after hours following <a href=\"https://seekingalpha.com/news/3211132-tempur-sealy-plunges-profit-revenue-warning\" target=\"_blank\">a cut in guidance</a>, and the pain is spreading to Select Comfort (SCSS), which isÂ <font color=\"red\">down 8.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3211152\" data-linked=\"Select Comfort stung by Tempur Sealy warning\" data-tweet=\"$SNBR - Select Comfort stung by Tempur Sealy warning https://seekingalpha.com/news/3211152-select-comfort-stung-tempur-sealy-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3211152-select-comfort-stung-tempur-sealy-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211149\" data-ts=\"1475009455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211149-galectins-gr-mdminus-02-flunks-mid-stage-nash-study-shares-off-44-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin&#39;s GR-MD-02 flunks mid-stage NASH study; shares off 44% after hours</a></h4><ul>\n<li>Nano cap Galectin Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a>) slumpsÂ <font color=\"red\">44%</font>Â after hours on robust volume in response to its announcement that a Phase 2a clinical trial assessing lead product candidate GR-MD-02 for the treatment of patients with nonalcoholic steatohepatitis (NASH) with advanced fibrosis failed to achieve its primary and secondary endpoints.</li>\n<li>The <a href=\"https://clinicaltrials.gov/ct2/show/NCT02421094?term=gr-md-02&amp;rank=6\" target=\"_blank\">primary endpoint</a> of the exploratory single-site, short-treatment duration (four months) randomized study was the mean change in liver fibrosis as measured by a magnetic resonance imaging (MRI) test called LiverMultiScan. The study also missed the secondary endpoints measuring liver stiffness as a surrogate for fibrosis as determined by FibroScan and magnetic resonance elastography (MRE). On the plus side, GR-MD-02 was observed to be safe and well tolerated with no serious adverse events reported.</li>\n<li>Putting a positive spin on the results, principal investigator Stephen Harrison, M.D., says, \"Although there was no apparent improvement in the three non-invasive tests for assessment of liver fibrosis in this four-month pilot trial, inhibition of galectin-3 with GR-MD-02 remains promising for treatment of NASH fibrosis. In regard to the potential activity of GR-MD-02, it is encouraging that there is an important clinical effect in moderate-to-severe psoriasis...\"</li>\n<li>The company will host a conference call at 5:30 pm ET to discuss the data.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211149\" data-linked=\"Galectin&#39;s GR-MD-02 flunks mid-stage NASH study; shares off 44% after hours\" data-tweet=\"$GALT - Galectin&#39;s GR-MD-02 flunks mid-stage NASH study; shares off 44% after hours https://seekingalpha.com/news/3211149-galectins-gr-mdminus-02-flunks-mid-stage-nash-study-shares-off-44-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3211149-galectins-gr-mdminus-02-flunks-mid-stage-nash-study-shares-off-44-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211148\" data-ts=\"1475008907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211148-oil-retraces-losses-after-inventory-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil retraces some losses after inventory decline</a></h4><ul>\n<li>The API reports an 832K barrel inventory draw vs. expectations for a build. Oil hasÂ <font color=\"green\">added about a quarterÂ </font>on the news to $44.75 per barrel, but remains lower on the dayÂ <font color=\"red\">by 2.5%</font>.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>Â <font color=\"green\">+0.6%</font>Â after hours</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/UGA\" title=\"The United States Gasoline ETF, LP\">UGA</a>, <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/UHN\" title=\"The United States Diesel-Heating Oil ETF, LP\">UHN</a>, <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>, <a href=\"https://seekingalpha.com/symbol/OILX\" title=\"Etracs S&amp;P GSCI Crude Oil Total Return Index ETN\">OILX</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211148\" data-linked=\"Oil retraces some losses after inventory decline\" data-tweet=\"$USO $OIL $UWTI - Oil retraces some losses after inventory decline https://seekingalpha.com/news/3211148-oil-retraces-losses-after-inventory-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3211148-oil-retraces-losses-after-inventory-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211143\" data-ts=\"1475008217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211143-futures-orders-nike-miss-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures orders at Nike miss expectations</a></h4><ul>     <li>Nike reports sales rose 10% in FQ1 on a constant currency basis.</li>     <li>Revenue by brand (ex-currency): Nike +10% to $8.5B, Converse +4% to $574M.</li>\n<li>Apparel sales and footwear sales both rose at a double-digit clip on a constant currency comparison, while equipment sales lagged at a 6% rate.</li>          <li>Global futures orders +7% ex-currency (+5% reported): North America +1%, Western Europe +9%, Central/Eastern Europe +9%, Greater China +19%, Japan +11%, Emerging Markets +10%.</li>     <li>Gross margin -50 bps Y/Y to 45.6% as higher selling prices helped to offset a higher mix of off-price sales and F/X swings.</li>     <li>The company ended the quarter with an inventory position up 11% Y/Y.</li>     <li>The effective tax rate was 2.5% for the period, a sharp drop from last year's mark of 18.4% due largely to an IRS issue resolution.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3211131-nike-beats-0_17-beats-revenue\" target=\"_blank\">Nike beats by $0.17, beats on revenue</a> (Sept. 27)</li>      <li>NKEÂ <font color=\"red\">-4.35%Â </font>after hours to $52.96 with the futures orders guidance missing expectations.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211143\" data-linked=\"Futures orders at Nike miss expectations\" data-tweet=\"Futures orders at Nike miss expectations https://seekingalpha.com/news/3211143-futures-orders-nike-miss-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3211143-futures-orders-nike-miss-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211141\" data-ts=\"1475008140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOMX\" target=\"_blank\">FOMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211141-foamix-pharma-launches-public-equity-offering-shares-ease-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foamix Pharma launches public equity offering; shares ease 5% after hours</a></h4><ul>\n<li>Foamix Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FOMX\" title=\"Foamix Pharmaceuticals\">FOMX</a>) initiates a public offering of common stock. Price, volume and terms have yet to be announced. Shares are downÂ <font color=\"red\">5%</font>Â after hours on light volume.</li>\n<li>\n<strong>Update</strong>: On September 28, the company announced that it priced 6M shares at $9.50. Underwriters over-allotment is an additional 900K shares. Closing date is September 30.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211141\" data-linked=\"Foamix Pharma launches public equity offering; shares ease 5% after hours\" data-tweet=\"$FOMX - Foamix Pharma launches public equity offering; shares ease 5% after hours https://seekingalpha.com/news/3211141-foamix-pharma-launches-public-equity-offering-shares-ease-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3211141-foamix-pharma-launches-public-equity-offering-shares-ease-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211134\" data-ts=\"1475007551\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211134-clinton-trump-tv-presidential-debate-is-watched-ever\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clinton-Trump TV presidential debate is most-watched ever</a></h4><ul>   <li>Final ratings are still coming together, but last night's presidential debate between Hillary Clinton and Donald Trump will be the <a href=\"http://www.hollywoodreporter.com/live-feed/debate-ratings-clinton-trump-showdown-932785\" target=\"_blank\">most-watched ever</a>.</li>    <li>With several networks in, the first presidential debate this season has hit 83.7M viewers, which would surpass the previous most-watched presidential debate, the sole debate between 1980 candidates Jimmy Carter and Ronald Reagan (80M viewers).</li>    <li>Of course, that viewer bounty isn't visited on just one network -- more than a dozen televised the event live and (at least during the debate) commercial-free -- but the overall result means a flood of ad dollars going to a variety of networks for pre- and post-debate ads, some of which looked more like the Super Bowl in terms of level of interest.</li>    <li>According to Nielsen's current numbers, the Big Four broadcast networks drew 49.1M viewers, up about 25% from 2012; NBC (<a href=\"https://seekingalpha.com/symbol/CMCSA\" title=\"Comcast Corporation\">CMCSA</a> <font color=\"green\">+0.6%</font>) with 18.2M, ABC (<a href=\"https://seekingalpha.com/symbol/DIS\" title=\"The Walt Disney Company\">DIS</a> <font color=\"red\">-0.3%</font>) with 13.5M, CBS (<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a> <font color=\"green\">+1.8%</font>) with 12.1M and Fox (<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Twenty-First Century Fox, Inc.\">FOX</a> <font color=\"green\">+2%</font>, <a href=\"https://seekingalpha.com/symbol/FOXA\" title=\"Twenty-First Century Fox, Inc.\">FOXA</a> <font color=\"green\">+1.7%</font>) with 5.3M. PBS drew 2.9M viewers, while Univision (<a href=\"https://seekingalpha.com/symbol/UVN\" title=\"Univision\">UVN</a>) added 2.5M and Telemundo 1.8M.</li>    <li>On cable, Fox News saw 11.4M viewers, with CNN (<a href=\"https://seekingalpha.com/symbol/TWX\" title=\"Time Warner Inc.\">TWX</a> <font color=\"green\">+2.3%</font>) slightly behind at 9.8M and MSNBC at 4.9M.</li>    <li>Local broadcast chains <a href=\"https://seekingalpha.com/news/3209965-gray-television-sinks-withdraws-guidance-political-ad-revenue\" target=\"_blank\">including Gray Television</a> (<a href=\"https://seekingalpha.com/symbol/GTN\" title=\"Gray Television, Inc.\">GTN</a> <font color=\"red\">-0.1%</font>) and <a href=\"https://seekingalpha.com/news/3209785-sinclair-broadcast-minus-5_9-percent-cuts-political-revenue-forecast\" target=\"_blank\">Sinclair Broadcast Group</a> (<a href=\"https://seekingalpha.com/symbol/SBGI\" title=\"Sinclair Broadcast Group, Inc.\">SBGI</a> <font color=\"green\">+1.5%</font>) have recently cut guidance for political revenues, with advertising spending disappointing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211134\" data-linked=\"Clinton-Trump TV presidential debate is most-watched ever\" data-tweet=\"$FOX $FOX $FOXA - Clinton-Trump TV presidential debate is most-watched ever https://seekingalpha.com/news/3211134-clinton-trump-tv-presidential-debate-is-watched-ever?source=tweet\" data-url=\"https://seekingalpha.com/news/3211134-clinton-trump-tv-presidential-debate-is-watched-ever\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>104&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211133\" data-ts=\"1475007502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTAS\" target=\"_blank\">CTAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211133-cintas-beats-0_18-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cintas beats by $0.18, beats on revenue</a></h4><ul>\n<li>Cintas (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CTAS\" title=\"Cintas Corporation\">CTAS</a>): FQ1 EPS of $1.26 <font color=\"green\">beats by $0.18</font>.</li>\n<li>Revenue of $1.29B (+7.5% Y/Y) <font color=\"green\">beats by $10M</font>.</li>\n<li>Shares <font color=\"green\">+2.3%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211133\" data-linked=\"Cintas beats by $0.18, beats on revenue\" data-tweet=\"$CTAS - Cintas beats by $0.18, beats on revenue https://seekingalpha.com/news/3211133-cintas-beats-0_18-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3211133-cintas-beats-0_18-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211132\" data-ts=\"1475007440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211132-tempur-sealy-plunges-on-profit-and-revenue-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tempur Sealy plunges on profit and revenue warning</a></h4><ul>\n<li>The company expects full-year adjusted EBITDA of $500M-$525M, down 5% at the midpoint from previous guidance. Net sales are seen as down 1-3% Y/Y.</li>\n<li>Full results are due on Oct. 27.</li>\n<li>CEO Scott Thompson: \"While our net sales are below expectations, our operational initiatives are going well and are continuing to drive considerable margin expansion.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/TPX\" title=\"Tempur Sealy International Inc.\">TPX</a>Â <font color=\"red\">-19.4%</font>Â after hours</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211132\" data-linked=\"Tempur Sealy plunges on profit and revenue warning\" data-tweet=\"$TPX - Tempur Sealy plunges on profit and revenue warning https://seekingalpha.com/news/3211132-tempur-sealy-plunges-on-profit-and-revenue-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3211132-tempur-sealy-plunges-on-profit-and-revenue-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211128\" data-ts=\"1475007098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211128-sonic-preliminary-fq4-results-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic preliminary FQ4 results disappoint</a></h4><ul>\n<li>\"The fourth quarter was below our expectations from both a sales and a profit perspective,\" says Sonic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SONC\" title=\"Sonic Corp.\">SONC</a>) CEO Cliff Hudson. \"The shortfall was largely driven by lower-than-expected traffic, reflecting lower consumer spending in restaurants and continued aggressive competitive activity.\"</li>\n<li>Same-store sales are estimated to have fallen about 2%, with a 3% decline at company drive-ins and a 1.8% fall at franchise units.</li>\n<li>Adjusted net income is seen at $0.43-$0.45 versus consensus $0.48.</li>\n<li>Full results are due on Oct. 24.</li>\n<li>SharesÂ <font color=\"red\">-1.75%</font>Â after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211128\" data-linked=\"Sonic preliminary FQ4 results disappoint\" data-tweet=\"$SONC - Sonic preliminary FQ4 results disappoint https://seekingalpha.com/news/3211128-sonic-preliminary-fq4-results-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3211128-sonic-preliminary-fq4-results-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211121\" data-ts=\"1475005488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTE\" target=\"_blank\">DTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211121-dte-energy-remains-top-pick-macquarie-following-deals-higher-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DTE Energy remains top pick at Macquarie following deals, higher guidance</a></h4><ul>     <li>DTEÂ Energy (<a href=\"https://seekingalpha.com/symbol/DTE\" title=\"DTE Energy Company\">DTE</a> <font color=\"red\">-1.5%</font>) remains the <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8500634/dte-energy-is-all-gassed-up-raises-guidance\" target=\"_blank\">top pick</a> among small- and mid-cap regulated utilities at Macquarie, which maintains its Outperform rating and raises its price target by $2 to $107, a day after <a href=\"https://seekingalpha.com/news/3210896-dte-energy-buy-1_3b-midstream-natural-gas-assets\" target=\"_blank\">buying $1.3B in natural gas pipeline assets</a> from M3 Midstream and Vega Energy Partners.</li>     <li>Macquarie sees the assets as \"attractive strategically given their location, contracts, diversified list of customers, potential for expansion and interconnection with DTE's existing systems,\" and estimates the deals will add to EPS by $0.04 (+0.8%) in 2017 and $0.15 (+2.3%) by 2020, ahead of DTE's own 2010 guidance of $0.10.</li>     <li>DTE raises its 2016 EPS guidance range to $5.09-$5.35 vs. its earlier estimate of $4.91-$5.19, and sees the deal increasing EPS starting in 2017 and adding $0.10 in 2020, according to a <a href=\"https://www.sec.gov/Archives/edgar/data/936340/000093634016000397/dteacquisitionfinal8k.htm\" target=\"_blank\">slide presentation</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211121\" data-linked=\"DTE Energy remains top pick at Macquarie following deals, higher guidance\" data-tweet=\"$DTE - DTE Energy remains top pick at Macquarie following deals, higher guidance https://seekingalpha.com/news/3211121-dte-energy-remains-top-pick-macquarie-following-deals-higher-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3211121-dte-energy-remains-top-pick-macquarie-following-deals-higher-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211120\" data-ts=\"1475004632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211120-j-p-morgan-sets-1000-price-target-on-amazon-sharesplus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.P. Morgan sets $1,000 price target on Amazon, shares +2%</a></h4><ul>\n<li>FollowingÂ recent <a href=\"https://seekingalpha.com/news/3209313-amazon-gets-1000-price-targets-rbc-capital-markets-evercore-isi\" target=\"_blank\">$1,000+ target raises</a> at RBC Capital Markets and Evercore ISI.</li>\n<li>\n<a href=\"https://www.ft.com/content/955a350b-7d89-37b5-8daa-6bc1e3e511f8\" target=\"_blank\">AnalystÂ Doug Anmuth</a>: \"We believe Amazon continues to show strong ability to take share of overall eCommerce, and its flexibility in pushing first-party versus third party inventory is a major advantage compared with other retailers.\" Further: \"Our price target is based on a sum-of-the-parts analysis as we believe this methodology appropriately attributes value to the company\u2019s large, fast-growing and surprisingly profitable \u2026Amazon Web Services segment, which Amazon continues to invest in.\"</li>\n<li>J.P Morgan previously held an Amazon (<a href=\"https://seekingalpha.com/symbol/AMZN\" title=\"Amazon.com, Inc.\">AMZN</a> <font color=\"green\">+1.8%</font>) target of $925 (current price $813.68).</li>\n<li>Overweight rating maintained.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211120\" data-linked=\"J.P. Morgan sets $1,000 price target on Amazon, shares +2%\" data-tweet=\"$AMZN - J.P. Morgan sets $1,000 price target on Amazon, shares +2% https://seekingalpha.com/news/3211120-j-p-morgan-sets-1000-price-target-on-amazon-sharesplus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3211120-j-p-morgan-sets-1000-price-target-on-amazon-sharesplus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211116\" data-ts=\"1475002805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211116-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INVT' title='Inventergy Global, Inc.'>OTC:INVT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/TTD' title='The Trade Desk'>TTD</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> MSDI <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/FDS' title='FactSet Research Systems Inc.'>FDS</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211116\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$INVT $LIVE $PI - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3211116-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3211116-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211113\" data-ts=\"1475001982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAR\" target=\"_blank\">CAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211113-car-rental-stocks-slide-on-european-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Car rental stocks slide on European concerns</a></h4><ul>     <li>Avis Budget (<a href=\"https://seekingalpha.com/symbol/CAR\" title=\"Avis Budget Group, Inc.\">CAR</a> <font color=\"red\">-7.1%</font>) is sharply lower after some unsettling comments from execs today at the Deutsche Bank's Leveraged Finance Conference.</li>\n<li>Demand in Europe fell off for Avis due to the combined impact of security concerns, Brexit, the Olympics, and economic factors.</li>\n<li>Avis conference presentation (<a href=\"http://edge.media-server.com/m/p/pfr834dk\" target=\"_blank\">webcast</a>)</li>\n<li>Shares of Hertz Global Holdings (<a href=\"https://seekingalpha.com/symbol/HTZ\" title=\"Hertz Global Holdings, Inc.\">HTZ</a> <font color=\"red\">-8.8%</font>) are faring even worse on the day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211113\" data-linked=\"Car rental stocks slide on European concerns\" data-tweet=\"$CAR $CAR $HTZ - Car rental stocks slide on European concerns https://seekingalpha.com/news/3211113-car-rental-stocks-slide-on-european-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3211113-car-rental-stocks-slide-on-european-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211106\" data-ts=\"1474999256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211106-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+8%</font>. TVIA <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/TROX' title='Tronox Inc.'>TROX</a> <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/VNR' title='Vanguard Natural Resources, LLC'>VNR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/BTG' title='B2Gold Corp.'>BTG</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ECR' title='Eclipse Resources'>ECR</a> <font color='red'>-8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3211106\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$SAEX $TVIAQ $TROX - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3211106-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3211106-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211102\" data-ts=\"1474998100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211102-big-pop-for-disinfectant-specialist-after-inking-deal-chipotle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big pop for disinfectant specialist after inking deal with Chipotle</a></h4><ul>\n<li>Chipotle (<a href=\"https://seekingalpha.com/symbol/CMG\" title=\"Chipotle Mexican Grill, Inc.\">CMG</a> <font color=\"red\">-0.2%</font>)Â announces it will use a special antimicrobial disinfectant solution produced byÂ PURE Bioscience (<a href=\"https://seekingalpha.com/symbol/PURE\" title=\"PURE Bioscience\">OTC:PURE</a>)Â in all U.S. restaurants.</li>\n<li>The disinfectant is expected to be productive in preventing notovirus outbreaks and bacteria contamination.</li>\n<li>The development is doing wonders for the shares of microcap Pure Bioscience.</li>\n<li>PURE<font color=\"green\"> +14.57</font>% to $1.14.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211102\" data-linked=\"Big pop for disinfectant specialist after inking deal with Chipotle\" data-tweet=\"$CMG $CMG $PURE - Big pop for disinfectant specialist after inking deal with Chipotle https://seekingalpha.com/news/3211102-big-pop-for-disinfectant-specialist-after-inking-deal-chipotle?source=tweet\" data-url=\"https://seekingalpha.com/news/3211102-big-pop-for-disinfectant-specialist-after-inking-deal-chipotle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211092\" data-ts=\"1474995736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211092-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/BOFI' title='BofI Holding, Inc.'>BOFI</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CXW' title='CoreCivic, Inc.'>CXW</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/IRT' title='Independence Realty Trust'>IRT</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211092\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$YRD $CCCR-OLD $BOFI - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3211092-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3211092-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211091\" data-ts=\"1474995662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VISN\" target=\"_blank\">VISN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211091-visionchina-media-back-in-nasdaq-compliance-after-filing-late-form\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VisionChina Media back in Nasdaq compliance after filing late form</a></h4><ul>   <li>VisionChina Media (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VISN\" title=\"VisionChina Media, Inc.\">VISN</a>) is <font color=\"green\">up 4.3%</font> today after noting it regained compliance with Nasdaq listing rules.</li>    <li>The company last week filed its annual report for the fiscal year ended last Dec. 31.</li>    <li>Nasdaq had informed the company it was out of compliance in May for not timely filing the Form 20-F.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211091\" data-linked=\"VisionChina Media back in Nasdaq compliance after filing late form\" data-tweet=\"$VISN - VisionChina Media back in Nasdaq compliance after filing late form https://seekingalpha.com/news/3211091-visionchina-media-back-in-nasdaq-compliance-after-filing-late-form?source=tweet\" data-url=\"https://seekingalpha.com/news/3211091-visionchina-media-back-in-nasdaq-compliance-after-filing-late-form\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211087\" data-ts=\"1474995130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211087-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RGSE' title='RGS Energy, Inc.'>RGSE</a> <font color='green'>+94%</font>. <a href='https://seekingalpha.com/symbol/GI' title='EndoChoice Holdings'>GI</a> <font color='green'>+89%</font>. <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/INVT' title='Inventergy Global, Inc.'>OTC:INVT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ACIU' title='AC Immune SA'>ACIU</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> <font color='red'>-16%</font>. AOI <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BTG' title='B2Gold Corp.'>BTG</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/VNR' title='Vanguard Natural Resources, LLC'>VNR</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/GBIM' title='GlobeImmune'>OTC:GBIM</a> <font color='red'>-10%</font>. SPU <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/LGND' title='Ligand Pharmaceuticals Incorporated'>LGND</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a> <font color='red'>-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211087\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$RGSE $GI $DRRX - Midday Gainers / Losers https://seekingalpha.com/news/3211087-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3211087-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211084\" data-ts=\"1474994591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211084-goprominus-5-on-djis-mavic-pro-drone-unveiling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro -5% on DJI&#39;s Mavic Pro drone unveiling</a></h4><ul>\n<li>GoPro (<a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"red\">-5%</font>)Â <a href=\"https://seekingalpha.com/news/3209592-gopro-plus-8-percent-unveils-hero-5-black-hero-5-session-karma\" target=\"_blank\">revealed</a> its drone offering, <a href=\"https://shop.gopro.com/karma\" target=\"_blank\">Karma</a>,Â early last week. Competitor DJI (<a href=\"https://seekingalpha.com/symbol/DJI\" title=\"DJI Innovations\">DJI</a>) today exhibits its rival product, <a href=\"http://store.dji.com/product/mavic-pro?site=brandsite&amp;from=buy_now_frontpage\" target=\"_blank\">Mavic Pro</a>.</li>\n<li>Mavic Pro is priced at $999 while Karma is priced at $799.</li>\n<li>With many overlapping features (foldable, mobile control etc.), varying performance, precision, price points and technological capabilities look to be the key factors in determining consumer preference.</li>\n<li>Shipping for the Mavic Pro begins in mid-October. GoPro's Karma will be available October 23.</li>\n<li><a href=\"https://youtu.be/tmNNe3TubsU\" target=\"_blank\">Live broadcast</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211084\" data-linked=\"GoPro -5% on DJI&#39;s Mavic Pro drone unveiling\" data-tweet=\"$GPRO $GPRO $DJII - GoPro -5% on DJI&#39;s Mavic Pro drone unveiling https://seekingalpha.com/news/3211084-goprominus-5-on-djis-mavic-pro-drone-unveiling?source=tweet\" data-url=\"https://seekingalpha.com/news/3211084-goprominus-5-on-djis-mavic-pro-drone-unveiling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211081\" data-ts=\"1474993729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PEGI\" target=\"_blank\">PEGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211081-pattern-energy-started-neutral-ubs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pattern Energy started at Neutral at UBS</a></h4><ul>     <li>Pattern Energy (<a href=\"https://seekingalpha.com/symbol/PEGI\" title=\"Pattern Energy Group Inc.\">PEGI</a> <font color=\"red\">-2.1%</font>) is initiated with a <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+UBS+Starts+Pattern+Energy+Group+%28PEGI%29+at+Neutral/12073219.html\" target=\"_blank\">Neutral rating</a> and $24 price target at UBS, which sees shares as trading only at a modest premium to its distributable cash flow target of  $20 and discount to its yield-based methodology of $28.</li>     <li>While shares only trade at a modest premium to DCF value, the firm emphasizes the discount is appropriate as long as PEGI has a separate parent private equity sponsor.</li>     <li>UBS also sees greater volatility associated with a largely wind portfolio and financial swaps on some deals.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211081\" data-linked=\"Pattern Energy started at Neutral at UBS\" data-tweet=\"$PEGI - Pattern Energy started at Neutral at UBS https://seekingalpha.com/news/3211081-pattern-energy-started-neutral-ubs?source=tweet\" data-url=\"https://seekingalpha.com/news/3211081-pattern-energy-started-neutral-ubs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211070\" data-ts=\"1474992088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211070-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EBF' title='Ennis, Inc.'>EBF</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/IBA' title='Industrias Bachoco, S.A.B. de C.V.'>IBA</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> AOI <font color='red'>-15%</font>. SPU <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CRI' title='Carter&#39;s, Inc.'>CRI</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3211070\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$EBF $SORL $IBA - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3211070-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3211070-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211063\" data-ts=\"1474990852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NG\" target=\"_blank\">NG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211063-novagold-upgraded-j-p-morgan-on-strength-of-donlin-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NovaGold upgraded at J.P. Morgan on strength of Donlin project</a></h4><ul>     <li>NovaGold Resources (<a href=\"https://seekingalpha.com/symbol/NG\" title=\"NovaGold Resources, Inc\">NG</a> <font color=\"green\">+2.3%</font>) is <a href=\"http://business.financialpost.com/news/mining/novagold-resources-inc-upgraded-as-spotlight-may-shift\" target=\"_blank\">upgraded</a> to Overweight from Neutral with a C$10.50 price target at J.P. Morgan, which says NG's 50%-owned Donlin gold project in Alaska should get permits next year.</li>     <li>The firm thinks NG will be motivated to push ahead with the project as 50% partner Barrick Gold\u2019s ([[ABX] <font color=\"red\">-2.7%</font>) production trends downward; NG has said it has a more than sufficient financial position to cover all  project activities and advance the project through completion of  permitting.</li>     <li>JPM expects companies focused on finding and developing new mines will put the  spotlight on NG.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211063\" data-linked=\"NovaGold upgraded at J.P. Morgan on strength of Donlin project\" data-tweet=\"$NG - NovaGold upgraded at J.P. Morgan on strength of Donlin project https://seekingalpha.com/news/3211063-novagold-upgraded-j-p-morgan-on-strength-of-donlin-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3211063-novagold-upgraded-j-p-morgan-on-strength-of-donlin-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211052\" data-ts=\"1474990349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211052-ligand-pharma-down-9-on-failure-of-amgens-phase-3-kyprolis-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ligand Pharma down 9% on failure of Amgen&#39;s Phase 3 Kyprolis study</a></h4><ul>\n<li>Ligand Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/LGND\" title=\"Ligand Pharmaceuticals Incorporated\">LGND</a> <font color=\"red\">-9.3%</font>) gets some rude treatment by the market in early trading. Shares are down on more than double normal volume in apparent response to the failure of Amgen's (<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a> <font color=\"red\">-1.1%</font>) Phase 3 study of a combination regimen including KYPROLIS (carfilzomib) for the treatment of certain multiple myeloma patients.</li>\n<li>Investors may be a bit premature on their perception that sales of KYPROLIS will be hampered by the negative results considering the company's statement that the standard-of-care for newly diagnosed multiple myeloma has moved away from the chemo agent <a href=\"https://en.wikipedia.org/wiki/Melphalan\" target=\"_blank\">melphalan</a>, which was a component of the combo regimens investigated in the study. The long-term trial commenced in March 2013.</li>\n<li>Ligand receives sales-based royalties from 1.5 - 3.0% from KYPROLIS. In the most recent four quarters, Amgen booked $611M in sales for the drug which translated to a 2.5% royalty for Ligand or ~$15.3M, almost 21% of the company's revenues over the same time frame.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211052\" data-linked=\"Ligand Pharma down 9% on failure of Amgen&#39;s Phase 3 Kyprolis study\" data-tweet=\"$LGND $LGND $AMGN - Ligand Pharma down 9% on failure of Amgen&#39;s Phase 3 Kyprolis study https://seekingalpha.com/news/3211052-ligand-pharma-down-9-on-failure-of-amgens-phase-3-kyprolis-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3211052-ligand-pharma-down-9-on-failure-of-amgens-phase-3-kyprolis-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211060\" data-ts=\"1474989972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDS\" target=\"_blank\">FDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211060-factsetminus-5_3-misses-in-q4-guides-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FactSet -5.3% as it misses in Q4, guides below consensus</a></h4><ul>   <li>FactSet (NYSE:<a href=\"https://seekingalpha.com/symbol/FDS\" title=\"FactSet Research Systems Inc.\">FDS</a>) is <font color=\"red\">off 5.3%</font> after wrapping up its fiscal year <a href=\"https://seekingalpha.com/news/3210947-factset-research-systems-misses-0_01-misses-revenue\" target=\"_blank\">with a miss</a> on top and bottom lines and light guidance for the upcoming quarter.</li>    <li>Revenues rose 9.7% and net income grew 8.5%. The company had taken an after-tax gain of $81.7M on the sale of its Market Metrics business in July.</li>    <li>Annual subscription value (a view into forward-looking revenues for 12 months) grew 8.8% organically, to $1.15B. Buy-side growth rate in ASV was 9%; sell-side was 7.6%. (Buy-side clients account for 82.6% of ASV.)</li>    <li>For Q1, the company's guiding to revenues of $286M-$292M (light of consensus for $293.9M) and EPS of $1.62-$1.66 (well off expectations for $1.72).</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3211060\" data-linked=\"FactSet -5.3% as it misses in Q4, guides below consensus\" data-tweet=\"$FDS - FactSet -5.3% as it misses in Q4, guides below consensus https://seekingalpha.com/news/3211060-factsetminus-5_3-misses-in-q4-guides-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3211060-factsetminus-5_3-misses-in-q4-guides-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211057\" data-ts=\"1474989786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THO\" target=\"_blank\">THO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211057-strong-report-from-thor-lifts-rv-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong report from Thor lifts RV sector</a></h4><ul> <li>Thor Industries (<a href=\"https://seekingalpha.com/symbol/THO\" title=\"Thor Industries, Inc.\">THO</a> <font color=\"green\">+3.2%</font>) tracks higher after the company blasts past estimates with its FQ4 report.</li> <li>A positive spin on industry demand has shares of other recreational vehicle makers on the move, including Arctic Cat (<a href=\"https://seekingalpha.com/symbol/ACAT\" title=\"Arctic Cat Inc.\">ACAT</a> <font color=\"green\">+1.9%</font>), Drew Industries(DW <font color=\"green\">+1%</font>), and Polaris Industries (<a href=\"https://seekingalpha.com/symbol/PII\" title=\"Polaris Industries Inc.\">PII</a> <font color=\"green\">+1.4%</font>). Supplier Patrick Industries (<a href=\"https://seekingalpha.com/symbol/PATK\" title=\"Patrick Industries, Inc.\">PATK</a> <font color=\"green\">+5%</font>) is also higher.</li> <li>\"During the fourth quarter, we saw continued year-over-year industry growth in most product categories and were able to capitalize on opportunities to expand our production capacity and output to meet the growing demand for affordably priced travel trailers and motorhomes,\" noted CEO Bob Martin.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3210867-thor-beats-0_24-beats-revenue\" target=\"_blank\">Thor beats by $0.24, beats on revenue</a> (Sept. 26)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3211057\" data-linked=\"Strong report from Thor lifts RV sector\" data-tweet=\"$THO $THO $ACAT - Strong report from Thor lifts RV sector https://seekingalpha.com/news/3211057-strong-report-from-thor-lifts-rv-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3211057-strong-report-from-thor-lifts-rv-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211055\" data-ts=\"1474989291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SJM\" target=\"_blank\">SJM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211055-j-m-smucker-slips-after-credit-suisse-capitulates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.M. Smucker slips after Credit Suisse capitulates</a></h4><ul> <li>Credit Suisse <a href=\"https://www.thestreet.com/story/13752964/1/jm-smucker-sjm-stock-lower-credit-suisse-cuts-to-neutral.html\" target=\"_blank\">lowers</a> its rating on J.M. Smucker (<a href=\"https://seekingalpha.com/symbol/SJM\" title=\"J. M. Smucker Company\">SJM</a> <font color=\"red\">-3%</font>) to a Neutral rating after having the food stock set at Outperform.</li> <li>The investment firm says it didn't properly factor in some of the challenges Smucker is facing, including hefty investments in the pet food business.</li> <li>The new price target from CS is $145 from $158.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3211055\" data-linked=\"J.M. Smucker slips after Credit Suisse capitulates\" data-tweet=\"$SJM - J.M. Smucker slips after Credit Suisse capitulates https://seekingalpha.com/news/3211055-j-m-smucker-slips-after-credit-suisse-capitulates?source=tweet\" data-url=\"https://seekingalpha.com/news/3211055-j-m-smucker-slips-after-credit-suisse-capitulates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211051\" data-ts=\"1474988806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211051-cruise-line-stocks-rally-after-carnival-says-zika-is-non-factor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cruise line stocks rally after Carnival says Zika is a non-factor</a></h4><ul> <li>There's a positive vibe in the cruise line sector a day after Carnival (<a href=\"https://seekingalpha.com/symbol/CCL\" title=\"Carnival Corporation\">CCL</a> <font color=\"green\">+3.8%</font>) reported pleasing numbers yesterday.</li> <li>Carnival execs said Zika was hardly a factor during the earnings call as they noted first-half 2017 bookings are ahead of last year's pace.</li> <li>CCL on Zika: \"We\u2019ve seen no material impact from Zika. We didn't get any cancelations or they\u2019re not enough to mention. We didn't see any impact on booking volume or timing or anything.\"</li>\n<li>Norwegian Cruise Line Holdings (<a href=\"https://seekingalpha.com/symbol/NCLH\" title=\"Norwegian Cruise Line Holdings Ltd.\">NCLH</a> <font color=\"green\">+2.4%</font>)Â and Royal Caribbean (<a href=\"https://seekingalpha.com/symbol/RCL\" title=\"Royal Caribbean Cruises Ltd.\">RCL</a> <font color=\"green\">+2.5%</font>) are both following their peer higher.</li> <li><a href=\"https://seekingalpha.com/article/4008544-carnival-corporations-ccl-ceo-arnold-donald-q3-2016-results-earnings-call-transcript\" target=\"_blank\">Carnival earnings call transcript</a></li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3210742-carnival-beats-0_03-beats-revenue\" target=\"_blank\">Carnival beats by $0.03, beats on revenue</a> (Sept. 26)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3210856-shares-carnival-backtrack-despite-solid-guidance\" target=\"_blank\">Shares of Carnival backtrack despite solid guidance</a> (Sept. 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211051\" data-linked=\"Cruise line stocks rally after Carnival says Zika is a non-factor\" data-tweet=\"$CCL $CCL $NCLH - Cruise line stocks rally after Carnival says Zika is a non-factor https://seekingalpha.com/news/3211051-cruise-line-stocks-rally-after-carnival-says-zika-is-non-factor?source=tweet\" data-url=\"https://seekingalpha.com/news/3211051-cruise-line-stocks-rally-after-carnival-says-zika-is-non-factor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211046\" data-ts=\"1474988682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOV\" target=\"_blank\">KTOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211046-kitov-pharmas-lead-product-candidate-shows-bioequivalence-to-reference-drug-lower-dose-nda-on\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kitov Pharma&#39;s lead product candidate shows bioequivalence to reference drug at a lower dose; NDA on tap for Q4; shares up 24%</a></h4><ul>\n<li>Thinly traded nano cap Kitov Pharmaceuticals Holdings (<a href=\"https://seekingalpha.com/symbol/KTOV\" title=\"Kitov Pharma Ltd.\">KTOV</a> <font color=\"green\">+24.2%</font>) perks up on almost a 4x surge in volume in response to its announcement of successful results in another bioequivalence study supporting lead product candidate KIT-302, this time with a dose of 2.5 mg of amlodipine. The company's previous bioequivalence study, with successful results announced on May 10, was performed with a 10 mg dose.</li>\n<li>\n<a href=\"http://kitovpharma.com/products-2/kit-302/\" target=\"_blank\">KIT-302</a>Â is a combination drug that treats osteoporosis-related pain (celecoxib, branded asÂ <a href=\"http://www.celebrex.com/?source=google&amp;HBX_PK=s_celebrex&amp;o=23040695%7C165564013%7C0&amp;skwid=43700007994682827&amp;sourcepoint=BS\" target=\"_blank\">Celebrex</a>Â by Pfizer) and hypertension (amlodipine besylate, branded asÂ <a href=\"http://labeling.pfizer.com/ShowLabeling.aspx?id=562\" target=\"_blank\">Norvasc</a>). Kitov expects to submit its New Drug Application (NDA) to the FDA by year end via the abbreviated 505(b)(2) pathway. If all goes well, approval could be granted in 2017.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211046\" data-linked=\"Kitov Pharma&#39;s lead product candidate shows bioequivalence to reference drug at a lower dose; NDA on tap for Q4; shares up 24%\" data-tweet=\"$KTOV - Kitov Pharma&#39;s lead product candidate shows bioequivalence to reference drug at a lower dose; NDA on tap for Q4; shares up 24% https://seekingalpha.com/news/3211046-kitov-pharmas-lead-product-candidate-shows-bioequivalence-to-reference-drug-lower-dose-nda-on?source=tweet\" data-url=\"https://seekingalpha.com/news/3211046-kitov-pharmas-lead-product-candidate-shows-bioequivalence-to-reference-drug-lower-dose-nda-on\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211049\" data-ts=\"1474988490\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211049-sec-fines-weatherford-140m-for-accounting-fraud\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SEC fines Weatherford $140M for accounting fraud</a></h4><ul>     <li>Weatherford International (<a href=\"https://seekingalpha.com/symbol/WFT\" title=\"Weatherford International Ltd.\">WFT</a> <font color=\"red\">-4.6%</font>) says it <a href=\"https://seekingalpha.com/filing/3235288\" target=\"_blank\">agrees to pay a $140M fine</a> to settle the previously disclosed SEC investigation over <a href=\"http://www.marketwatch.com/story/sec-fines-weatherford-intl-140-million-for-allegedly-inflating-earnings-2016-09-27\" target=\"_blank\">allegedly inflating earnings</a> by using deceptive income tax accounting.</li>     <li>Two former WFT top accounting execs allegedly made inappropriate adjustments to fill gaps and meet goals for the company's effective tax rate that was touted to analysts and investors; WFT restated its financial statements three times during 2011-12 to correct the misstatements.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211049\" data-linked=\"SEC fines Weatherford $140M for accounting fraud\" data-tweet=\"$WFT $WFTIQ - SEC fines Weatherford $140M for accounting fraud https://seekingalpha.com/news/3211049-sec-fines-weatherford-140m-for-accounting-fraud?source=tweet\" data-url=\"https://seekingalpha.com/news/3211049-sec-fines-weatherford-140m-for-accounting-fraud\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211024\" data-ts=\"1474988422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211024-healthcare-top-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GI' title='EndoChoice Holdings'>GI</a> <font color='green'>+89%</font>. <a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/MRTX' title='Mirati Therapeutics, Inc.'>MRTX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay'>VRAY</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LGND' title='Ligand Pharmaceuticals Incorporated'>LGND</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3211024\" data-linked=\"Healthcare - Top Gainers / Losers as of 11:00 am\" data-tweet=\"$GI $KTOV $MRTX - Healthcare - Top Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3211024-healthcare-top-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3211024-healthcare-top-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211047\" data-ts=\"1474988322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CACQ\" target=\"_blank\">CACQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211047-caesars-acquisition-company-pulls-back-from-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars Acquisition Company pulls back from 52-week high</a></h4><ul> <li>Shares of Caesars Acquisition Company (<a href=\"https://seekingalpha.com/symbol/CACQ\" title=\"Caesars Acquisition Company\">CACQ</a> <font color=\"red\">-3.7%</font>) are lower after a brisk run-up over the last few day.</li> <li>Investors continue to hedge their bets on Caesars Acquisition depending upon the progress of the reorganization of the bankrupt Caesars operating unit.</li> <li>CACQ is coming down from the 52-week high of $13.00 it carved out yesterday.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3211047\" data-linked=\"Caesars Acquisition Company pulls back from 52-week high\" data-tweet=\"$CACQ - Caesars Acquisition Company pulls back from 52-week high https://seekingalpha.com/news/3211047-caesars-acquisition-company-pulls-back-from-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3211047-caesars-acquisition-company-pulls-back-from-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211042\" data-ts=\"1474987475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STXS\" target=\"_blank\">STXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211042-stereotaxis-nabs-24m-in-equity-financing-shares-up-25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stereotaxis nabs $24M in equity financing; shares up 25%</a></h4><ul>\n<li>Thinly traded nano cap Stereotaxis (<a href=\"https://seekingalpha.com/symbol/STXS\" title=\"Stereotaxis, Inc.\">STXS</a> <font color=\"green\">+25.4%</font>) is up on increased volume in response to its announcement that it has secured $24M in equity financing via the private placement of convertible stock with a conversion price of $0.65. The company will raise an additional $25.8M if all the accompanying warrants are exercised.</li>\n<li>The company has also reached agreement with creditor Healthcare Royalty Partners to satisfy its $18.4M outstanding debt with a payment of $13M, a good prudent move since the interest rate was an onerous 16%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211042\" data-linked=\"Stereotaxis nabs $24M in equity financing; shares up 25%\" data-tweet=\"$STXS - Stereotaxis nabs $24M in equity financing; shares up 25% https://seekingalpha.com/news/3211042-stereotaxis-nabs-24m-in-equity-financing-shares-up-25?source=tweet\" data-url=\"https://seekingalpha.com/news/3211042-stereotaxis-nabs-24m-in-equity-financing-shares-up-25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211038\" data-ts=\"1474986686\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRI\" target=\"_blank\">CRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211038-carters-heads-south-after-wells-fargo-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carter&#39;s heads south after Wells Fargo cut</a></h4><ul> <li>Carter's (<a href='https://seekingalpha.com/symbol/CRI' title='Carter&#39;s, Inc.'>CRI</a> <font color='red'>-3.9%</font>) falls after Wells Fargo <a href=\"https://www.marketbeat.com/stocks/NYSE/CRI/\" target=\"_blank\">downgrades</a> the retailer to Market Perform from Outperform.</li> <li>Wells made a late call in pulling its bullish outlook on Carter's, with shares already down 13% since early summer.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3211038\" data-linked=\"Carter&#39;s heads south after Wells Fargo cut\" data-tweet=\"$CRI - Carter&#39;s heads south after Wells Fargo cut https://seekingalpha.com/news/3211038-carters-heads-south-after-wells-fargo-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3211038-carters-heads-south-after-wells-fargo-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211036\" data-ts=\"1474986441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NADL\" target=\"_blank\">NADL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211036-north-atlantic-drilling-says-statoil-cancels-rig-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">North Atlantic Drilling says Statoil cancels rig contract</a></h4><ul>     <li>North American Drilling (<a href=\"https://seekingalpha.com/symbol/NADL\" title=\"North Atlantic Drilling Ltd.\">NADL</a> <font color=\"red\">-4.1%</font>) is sharply lower after Statoil (STO <font color=\"red\">-2%</font>) <a href=\"http://www.nadlcorp.com/modules/module_123/proxy.asp?C=42&amp;I=2619&amp;D=2&amp;mid=224\" target=\"_blank\">canceled its drilling contract</a> for NADL's West Epsilon jack-up about two months before expiration; Seadrill (<a href=\"https://seekingalpha.com/symbol/SDRL\" title=\"Seadrill Limited (New)\">SDRL</a> <font color=\"red\">-2.2%</font>), which owns ~70% of NADL, also is lower.</li>     <li>NADL says it will receive an $11M lump sum payment because of the early termination.</li>     <li>The rig's dayrate is $247K, so the cancellation means <a href=\"https://seekingalpha.com/article/4008662-north-atlantic-drilling-statoil-terminates-earlier-jack-west-epsilon-pays-11-million-cash\" target=\"_blank\">~$14M in lost backlog</a>; NADL's total backlog is now an estimated $370M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211036\" data-linked=\"North Atlantic Drilling says Statoil cancels rig contract\" data-tweet=\"$NADL $NADL $EQNR - North Atlantic Drilling says Statoil cancels rig contract https://seekingalpha.com/news/3211036-north-atlantic-drilling-says-statoil-cancels-rig-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3211036-north-atlantic-drilling-says-statoil-cancels-rig-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211035\" data-ts=\"1474986401\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUV\" target=\"_blank\">LUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211035-airline-stocks-perk-up-after-favorable-macro-mix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airline stocks perk up after favorable macro mix</a></h4><ul> <li>Airline stocks are pushing higher, led by a jump in Southwest Airlines (<a href=\"https://seekingalpha.com/symbol/LUV\" title=\"Southwest Airlines Co.\">LUV</a> <font color=\"green\">+3.1%</font>). A mix of macroeconomic factors, including a drop in oil prices and improved consumer confidence readings could be helping to lift sentiment on the drowsy sector.</li> <li>Gainers include American Airlines Group (<a href=\"https://seekingalpha.com/symbol/AAL\" title=\"American Airlines Group\">AAL</a> <font color=\"green\">+2.6%</font>), Hawaiian Holdings (<a href=\"https://seekingalpha.com/symbol/HA\" title=\"Hawaiian Holdings, Inc.\">HA</a> <font color=\"green\">+2.3%</font>), Delta Air Lines (<a href=\"https://seekingalpha.com/symbol/DAL\" title=\"Delta Air Lines, Inc.\">DAL</a> <font color=\"green\">+2.2%</font>), and JetBlue Airways (<a href=\"https://seekingalpha.com/symbol/JBLU\" title=\"JetBlue Airways Corporation\">JBLU</a> <font color=\"green\">+2.1%</font>).</li>\n<li>Related ETF: <a href=\"https://seekingalpha.com/symbol/JETS\" title=\"U.S. Global Jets ETF\">JETS</a>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3211035\" data-linked=\"Airline stocks perk up after favorable macro mix\" data-tweet=\"$LUV $LUV $AAL - Airline stocks perk up after favorable macro mix https://seekingalpha.com/news/3211035-airline-stocks-perk-up-after-favorable-macro-mix?source=tweet\" data-url=\"https://seekingalpha.com/news/3211035-airline-stocks-perk-up-after-favorable-macro-mix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211034\" data-ts=\"1474986345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211034-deutsche-bank-turns-higher-after-doj-comments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank turns higher after DOJ comments</a></h4><ul>\n<li>Banks could have and can still spare themselves a lot of pain by cooperating early and often, <a href=\"http://www.bloomberg.com/news/articles/2016-09-27/u-s-urges-cooperation-from-banks-to-settle-mortgage-cases\" target=\"_blank\">says Bill Baer</a>, the DOJ's number three man.</li>\n<li>Baer is speaking about the crisis-era mortgage settlements, some of which ran into the tens of billions of dollars. Banks like Deutsche Bank (NYSE:<a href=\"https://seekingalpha.com/symbol/DB\" title=\"Deutsche Bank AG\">DB</a>) and <a href=\"https://seekingalpha.com/symbol/RBS\" title=\"The Royal Bank of Scotland Group plc\">RBS</a> have yet to settle, and his message to the lenders seems to be: Submit quickly, and we'll throttle back the fines a bit.</li>\n<li>Deutsche of late has come under extreme pressure, in part, thanks to rumors the DOJ is seeking $14B to settle. Down another 3% earlier this morning, the stock has turned marginally higher.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211034\" data-linked=\"Deutsche Bank turns higher after DOJ comments\" data-tweet=\"$DB $DB $RBS - Deutsche Bank turns higher after DOJ comments https://seekingalpha.com/news/3211034-deutsche-bank-turns-higher-after-doj-comments?source=tweet\" data-url=\"https://seekingalpha.com/news/3211034-deutsche-bank-turns-higher-after-doj-comments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211025\" data-ts=\"1474984999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNC\" target=\"_blank\">SSNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211025-ss-and-c-technologies-holdings-upgraded-to-overweight-morgan-stanleyplus-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SS&amp;C Technologies Holdings upgraded to Overweight at Morgan Stanley; +3%</a></h4><ul>\n<li>Analyst Brian Essex <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8498918/ss-c-technologies-upgraded-to-overweight-at-morgan-stanl\" target=\"_blank\">projects</a> organic revenue to grow, margins to increase and cash flow to improve.</li>\n<li>Moves from Equal Weight rating previously and raises price target from $37 to $39 (current price $32.71).</li>\n<li>SS&amp;C Technologies Holdings (<a href=\"https://seekingalpha.com/symbol/SSNC\" title=\"SS&amp;C Technologies Holdings, Inc.\">SSNC</a> <font color=\"green\">+2.9%</font>)Â is tradingÂ <font color=\"green\">up over 23%</font>Â on the last three months andÂ <font color=\"red\">down slightly over 5%</font>Â on the year.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211025\" data-linked=\"SS&amp;C Technologies Holdings upgraded to Overweight at Morgan Stanley; +3%\" data-tweet=\"$SSNC - SS&amp;C Technologies Holdings upgraded to Overweight at Morgan Stanley; +3% https://seekingalpha.com/news/3211025-ss-and-c-technologies-holdings-upgraded-to-overweight-morgan-stanleyplus-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3211025-ss-and-c-technologies-holdings-upgraded-to-overweight-morgan-stanleyplus-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211018\" data-ts=\"1474984602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211018-mexican-markets-say-clinton-won-debate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mexican markets say Clinton won debate</a></h4><ul>\n<li>The Mexican peso has been as good of a gauge as any for tracking the odds of a Trump victory in November. Prior to last night's debate, it had tumbled to an all-time low vs. the dollar alongside Trump's rise in the polls.</li>\n<li>\n<a href=\"http://www.bloomberg.com/quote/USDMXN:CUR\" target=\"_blank\">It's surging</a> this morning though,Â <font color=\"green\">up 1.5%</font>Â against the greenback. The iShares MSCI Mexico ETF (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/EWW\" title=\"iShares MSCI Mexico Capped ETF\">EWW</a>) isÂ <font color=\"green\">higher by 1.95%</font>Â in early action.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/EWW\" title=\"iShares MSCI Mexico Capped ETF\">EWW</a>, <a href=\"https://seekingalpha.com/symbol/MXF\" title=\"Mexico Fund\">MXF</a>, <a href=\"https://seekingalpha.com/symbol/MXE\" title=\"Mexico Equity&amp;Income Fund\">MXE</a>, <a href=\"https://seekingalpha.com/symbol/UMX\" title=\"ProShares Ultra MSCI Mexico Capped IMI ETF\">UMX</a>, <a href=\"https://seekingalpha.com/symbol/DBMX\" title=\"Deutsche X-trackers MSCI Mexico Hedged Equity ETF\">DBMX</a>, <a href=\"https://seekingalpha.com/symbol/SMK\" title=\"ProShares UltraShort MSCI Mexico Capped IMI ETF\">SMK</a>, <a href=\"https://seekingalpha.com/symbol/QMEX\" title=\"SPDR MSCI Mexico Quality Mix ETF\">QMEX</a>, <a href=\"https://seekingalpha.com/symbol/HEWW\" title=\"iShares Currency Hedged MSCI Mexico ETF\">HEWW</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3211018\" data-linked=\"Mexican markets say Clinton won debate\" data-tweet=\"$EWW $MXF $MXE - Mexican markets say Clinton won debate https://seekingalpha.com/news/3211018-mexican-markets-say-clinton-won-debate?source=tweet\" data-url=\"https://seekingalpha.com/news/3211018-mexican-markets-say-clinton-won-debate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211017\" data-ts=\"1474984084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211017-two-chesapeake-directors-including-icahn-rep-resign\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two Chesapeake directors, including Icahn rep, resign</a></h4><ul>     <li>Chesapeake Energy (<a href=\"https://seekingalpha.com/symbol/CHK\" title=\"Chesapeake Energy Corporation\">CHK</a> <font color=\"red\">-5.6%</font>) discloses the <a href=\"https://www.sec.gov/Archives/edgar/data/895126/000089512616000559/a8-k2016x09x23reresignatio.htm\" target=\"_blank\">resignation of two board members</a>, including a representative of activist investor Carl Icahn, a week after Icahn cut his holdings in the company by more than half to ~4.5%.</li>     <li>Vincent Intrieri, who has served as senior managing director of Icahn Capital, had served on CHK's board since 2012, when CHK named four new independent directors, three proposed by then-largest shareholder Southeastern Asset Management and one proposed by Icahn.</li>     <li>John Lipinski, the other departing director, had served on CHK's board since 2014.</li>     <li>CHK says the resignations were not the result of any disagreement, but offers no further explanation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211017\" data-linked=\"Two Chesapeake directors, including Icahn rep, resign\" data-tweet=\"$CHK - Two Chesapeake directors, including Icahn rep, resign https://seekingalpha.com/news/3211017-two-chesapeake-directors-including-icahn-rep-resign?source=tweet\" data-url=\"https://seekingalpha.com/news/3211017-two-chesapeake-directors-including-icahn-rep-resign\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211007\" data-ts=\"1474983979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMMT\" target=\"_blank\">SMMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211007-fda-designates-summits-ezutromid-rare-pediatric-disease-for-treatment-of-duchenne-muscular\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA designates Summit&#39;s ezutromid as Rare Pediatric Disease for treatment of Duchenne muscular dystrophy</a></h4><ul> <li>Summit Therapeutics (<a href=\"https://seekingalpha.com/symbol/SMMT\" title=\"Summit Therapeutics\">SMMT</a> <font color=\"red\">-8.8%</font>)Â announces it has received Rare Pediatric Disease designation from the FDA for Phase 2-stageÂ <a href=\"https://clinicaltrials.gov/ct2/show/NCT02056808\" target=\"_blank\">ezutromid</a>Â for the treatment of <a href=\"https://www.mda.org/disease/duchenne-muscular-dystrophy\" target=\"_blank\">Duchenne muscular dystrophy</a>Â (DMD). As a utrophin modulator, ezutromid has potential as a disease-modifying treatment for all patients with the fatal muscle wasting disease DMD, regardless of their underlying dystrophin gene mutation.</li>\n<li>DMD is a progressive muscle wasting disease that affects around 50,000 boys and young men in the developed world. The disease is caused by different genetic faults in the gene that encodes <a href=\"https://en.wikipedia.org/wiki/Dystrophin\" target=\"_blank\">dystrophin</a>, a protein that is essential for the healthy function of all muscles. There is currently no cure for DMD and life expectancy is into the late twenties. <a href=\"https://en.wikipedia.org/wiki/Utrophin\" target=\"_blank\">Utrophin</a> protein is functionally and structurally similar to dystrophin.</li>\n<li>The FDA defines \u2019Rare Pediatric Disease\u2019 as a disease that primarily affects individuals aged from birth to 18 years and affects fewer than 200,000 persons in the US.</li>\n<li>If ezutromid is approved, Summit will receive Priority Review Voucher that can be used for a different product or it can be sold to another company. They are quite valuable. In 2014, AbbVie bought one from United Therapeutics for $350M.</li>\n<li>\n<strong>Update</strong>: <a href=\"https://slingshotinsights.com/\" target=\"_blank\">Slingshot Insights</a> has proposed an <a href=\"https://slingshotinsights.com/projects/171\" target=\"_blank\">expert interview</a> on ezutromid's market potential.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3211007\" data-linked=\"FDA designates Summit&#39;s ezutromid as Rare Pediatric Disease for treatment of Duchenne muscular dystrophy\" data-tweet=\"$SMMT - FDA designates Summit&#39;s ezutromid as Rare Pediatric Disease for treatment of Duchenne muscular dystrophy https://seekingalpha.com/news/3211007-fda-designates-summits-ezutromid-rare-pediatric-disease-for-treatment-of-duchenne-muscular?source=tweet\" data-url=\"https://seekingalpha.com/news/3211007-fda-designates-summits-ezutromid-rare-pediatric-disease-for-treatment-of-duchenne-muscular\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211003\" data-ts=\"1474982374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLDP\" target=\"_blank\">BLDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211003-volkswagen-audi-accelerate-fuel-cell-technology-program-ballard\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volkswagen, Audi accelerate fuel cell technology program with Ballard</a></h4><ul>     <li>Ballard Power (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BLDP\" title=\"Ballard Power Systems, Inc.\">BLDP</a>)Â <font color=\"green\">+4.9%</font> premarket after saying that Audi has issued purchase orders to accelerate key development activities under BLDP's Technology Solutions program.</li>     <li>As previously announced, BLDP's six-year engineering services contract with Volkswagen (VLKAY) runs to March 2019 at an estimated value of $80M-$112M, with an optional two-year extension.</li>     <li>VW recently transferred responsibility for fuel cell development to its Audi brand, and is accelerating the timeline for series production, BLDP says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3211003\" data-linked=\"Volkswagen, Audi accelerate fuel cell technology program with Ballard\" data-tweet=\"$BLDP $BLDP $VWAGY - Volkswagen, Audi accelerate fuel cell technology program with Ballard https://seekingalpha.com/news/3211003-volkswagen-audi-accelerate-fuel-cell-technology-program-ballard?source=tweet\" data-url=\"https://seekingalpha.com/news/3211003-volkswagen-audi-accelerate-fuel-cell-technology-program-ballard\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3211000\" data-ts=\"1474982189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3211000-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GI' title='EndoChoice Holdings'>GI</a> <font color='green'>+89%</font>. <a href='https://seekingalpha.com/symbol/KITE' title='Kite Pharma'>KITE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SHIP' title='Seanergy Maritime Holdings Corp'>SHIP</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/PIRS' title='Pieris Pharmaceuticals, Inc.'>PIRS</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+7%</font>. DNAI <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/PERI' title='Perion Network Ltd.'>PERI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/CASC' title='Cascadian Therapeutics, Inc'>CASC</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SXL' title='Sunoco Logistics Partners, L.P.'>SXL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/RICE' title='Rice Energy Inc'>RICE</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NAT' title='Nordic American Tankers Limited'>NAT</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3211000\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$GI $KITE $INFI - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3211000-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3211000-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210977\" data-ts=\"1474979871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNM\" target=\"_blank\">ATNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210977-actinium-initiates-mid-stage-clinical-trial-of-actimab-in-patients-aml-over-age-60-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Actinium initiates mid-stage clinical trial of Actimab-A in patients with AML over age 60; shares rise 5% premarket</a></h4><ul>\n<li>Actinium Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ATNM\" title=\"Actinium Pharmaceuticals, Inc.\">ATNM</a>) initiatesÂ a Phase 2 clinical trial of <a href=\"http://www.actiniumpharma.com/product-pipeline/actimab-a\" target=\"_blank\">Actimab-A</a> in patients newly diagnosed with <a href=\"https://medlineplus.gov/acutemyeloidleukemia.html\" target=\"_blank\">Acute Myeloid Leukemia</a> (AML) who are over the age of 60. Actimab-A, Actinium's most advanced alpha particle immunotherapy (APIT) program, consists of the CD33-targeting monoclonal antibody, HuM195, and the alpha-emitting radioisotope, Actinium-225.</li>\n<li>Actinium-225 gives off high-energy alpha particles as it decays which kills cancer cells.</li>  <li>The <a href=\"https://clinicaltrials.gov/ct2/show/NCT02575963?term=actinium+pharmaceuticals&amp;rank=2\" target=\"_blank\">open-label study</a> will enroll 53 patients. The primary endpoint is the complete response rate defined as complete remission or complete remission with incomplete platelet recovery.Â The secondary endpoint is overall survival. Top-line data should be available in H2 2017.</li>\n<li>Shares are upÂ <font color=\"green\">5%</font>Â premarket on modest volume.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3210977\" data-linked=\"Actinium initiates mid-stage clinical trial of Actimab-A in patients with AML over age 60; shares rise 5% premarket\" data-tweet=\"$ATNM - Actinium initiates mid-stage clinical trial of Actimab-A in patients with AML over age 60; shares rise 5% premarket https://seekingalpha.com/news/3210977-actinium-initiates-mid-stage-clinical-trial-of-actimab-in-patients-aml-over-age-60-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3210977-actinium-initiates-mid-stage-clinical-trial-of-actimab-in-patients-aml-over-age-60-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210986\" data-ts=\"1474979765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210986-gilead-cut-leerink-shares-lower-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead cut at Leerink, shares lower premarket</a></h4><ul>\n<li>Leerink'sÂ Geoffrey Porges downgrades Gilead (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a>) to Market Perform from Buy. Lowers price target to $94 from $112.</li>\n<li>Says GILD'sÂ hepatitis C franchise revenue forecasts have \u201cturned outright bearish.\u201d Notes that the U.S. hepatitis C market is \u201cin steady secular decline,\u201d and that global trends are similar.</li>\n<li>Notes that AbbVie (NYSE:<a href=\"https://seekingalpha.com/symbol/ABBV\" title=\"AbbVie Inc.\">ABBV</a>) will soon have a 2-drug single pill combination drug, with Merck and J&amp;J combos to follow.</li>\n<li>Says management has been slow to address HCV erosion. \"Cynics will suggest that this scenario was always in the offing, and to an extent that is true, but we believed Gilead had more visibility to the availability of patients to sustain its market, share and price than we did. This does not appear to be the case; in fact Gilead has been surprised by the slowing in patient volume around the world.\"</li>\n<li>SharesÂ <font color=\"red\">-1.5%</font>Â premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210986\" data-linked=\"Gilead cut at Leerink, shares lower premarket\" data-tweet=\"$GILD $GILD $ABBV - Gilead cut at Leerink, shares lower premarket https://seekingalpha.com/news/3210986-gilead-cut-leerink-shares-lower-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3210986-gilead-cut-leerink-shares-lower-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>91&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210984\" data-ts=\"1474979509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPW\" target=\"_blank\">MPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210984-medical-properties-trustminus-3_3-after-upsized-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medical Properties Trust -3.3% after upsized capital raise</a></h4><ul>\n<li>The company sold 50M shares, rather than 33.5M, and priced the sale at $14.50 each. The underwriters have a 7.5M greenshoe option. Net proceeds are estimated at $695.1M, or $799.5M if the underwriters exercise that option in full.</li>\n<li>Proceeds will be used to help fund the acquisition of hospitals from Steward Health Care System.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/MPW\" title=\"Medical Properties Trust, Inc.\">MPW</a>Â <font color=\"red\">-3.3%</font>Â premarket to $14.50.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3210868-medical-properties-trust-makes-1_25b-acquisition\" target=\"_blank\">Medical Properties Trust makes $1.25B acquisition</a> (Sept. 26)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210984\" data-linked=\"Medical Properties Trust -3.3% after upsized capital raise\" data-tweet=\"$MPW - Medical Properties Trust -3.3% after upsized capital raise https://seekingalpha.com/news/3210984-medical-properties-trustminus-3_3-after-upsized-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3210984-medical-properties-trustminus-3_3-after-upsized-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210983\" data-ts=\"1474979289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210983-deutsche-bank-slide-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank slide continues</a></h4><ul>\n<li>\n<font color=\"red\">Down another 3%</font>Â in Frankfurt action, Deutsche Bank (NYSE:<a href=\"https://seekingalpha.com/symbol/DB\" title=\"Deutsche Bank AG\">DB</a>) is at new all-time lows over concerns about its financial health and a German government <a href=\"http://www.bloomberg.com/news/articles/2016-09-26/deutsche-bank-returns-as-merkel-s-election-year-sparring-partner?utm_content=business&amp;utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social&amp;cmpid%3D=socialflow-twitter-business\" target=\"_blank\">insisting it won't come</a> to bank's relief.</li>\n<li>\"Anything that looks like giving money to the financial industry would be met with particular criticism in an election year,\u201d says business professor Joerg Rocholl. Angela Merkel is mulling a run for a fourth term and already has enough issues on her plate, plus she's been keeping her distance from the bank after her support of the lender during the financial crisis cost her plenty of political points.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210983\" data-linked=\"Deutsche Bank slide continues\" data-tweet=\"$DB - Deutsche Bank slide continues https://seekingalpha.com/news/3210983-deutsche-bank-slide-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3210983-deutsche-bank-slide-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210978\" data-ts=\"1474978754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210978-another-step-forward-for-caesars-out-of-legal-quagmire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another step forward for Caesars out of legal quagmire</a></h4><ul> <li>Caesars Entertainment (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CZR\" title=\"Caesars Entertainment\">CZR</a>) says major creditors support the new plan and agreements covering the reorganization of its operating unit.</li> <li>The company expects to obtain the necessary creditor votes to conclude the bankruptcy proceedings in 2017.</li> <li>Shares of Caesars are <font color=\"red\">down 5.50%</font> in early premarket trading after a 26% pop over the last three sessions. Though the casino stock has been hard to get a handle on amid the legal morass, next year could bring some grounded analysis on the underlying business.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210978\" data-linked=\"Another step forward for Caesars out of legal quagmire\" data-tweet=\"$CZR - Another step forward for Caesars out of legal quagmire https://seekingalpha.com/news/3210978-another-step-forward-for-caesars-out-of-legal-quagmire?source=tweet\" data-url=\"https://seekingalpha.com/news/3210978-another-step-forward-for-caesars-out-of-legal-quagmire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210955\" data-ts=\"1474975662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVO\" target=\"_blank\">NVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210955-novo-nordisk-announces-dkk3_4b-share-repurchase-programme\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novo Nordisk announces DKK3.4B share repurchase programme</a></h4><ul>\n<li>Novo Nordisk (<a href=\"https://seekingalpha.com/symbol/NVO\" title=\"Novo Nordisk A/S\">NVO</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/353278/000117184316012278/f6k_092616.htm\" target=\"_blank\">announces</a> that the company will repurchase B shares for an amount up to DKK 3.4B ($510M) in the period from August 5 to October 26.</li>\n<li>This programme is part of the overall share repurchase programme of up to DKK 14B to be executed during a 12-month period beginning February 3, 2016.</li>\n<li>Shares are downÂ <font color=\"red\">1%</font>Â premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210955\" data-linked=\"Novo Nordisk announces DKK3.4B share repurchase programme\" data-tweet=\"$NVO - Novo Nordisk announces DKK3.4B share repurchase programme https://seekingalpha.com/news/3210955-novo-nordisk-announces-dkk3_4b-share-repurchase-programme?source=tweet\" data-url=\"https://seekingalpha.com/news/3210955-novo-nordisk-announces-dkk3_4b-share-repurchase-programme\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210957\" data-ts=\"1474975427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210957-goldman-slashes-oil-price-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman slashes oil price outlook</a></h4><ul>\n<li>Warning supplies will continue to outpace demand regardless of what OPEC might say or do at its meeting this week, the Goldman Sachs team ofÂ Damien Courvalin and Jeffrey Currie <a href=\"http://www.marketwatch.com/story/goldman-cuts-q4-wti-oil-forecast-to-43-a-barrel-from-50-2016-09-27\" target=\"_blank\">cut their forecast for crude oil</a> in Q4 to $43 per barrel from $50.</li>\n<li>\"We find that the potential for less disruptions and still relatively high net long speculative positioning leave risks skewed to the downside into year-end.\"</li>\n<li>They expect a ramp in production from places likeÂ Kazakhstan, Russia and Canada, and with the demand outlook unchanged, this makes for an inventory build of 400K barrels per day in Q4 vs. their previous estimate for a 300K barrel per day draw.</li>\n<li>Texas Tea isÂ <font color=\"red\">down 1.7%</font>Â to $45.16 per barrel. <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>Â <font color=\"red\">-1.45%</font>Â premarket.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/USO\" title=\"The United States Oil ETF, LP\">USO</a>, <a href=\"https://seekingalpha.com/symbol/OIL\" title=\"iPath S&amp;P Crude Oil Total Return Index ETN\">OIL</a>, <a href=\"https://seekingalpha.com/symbol/UWTI\" title=\"VelocityShares 3x Long Crude Oil ETN\">UWTI</a>, <a href=\"https://seekingalpha.com/symbol/UCO\" title=\"ProShares Ultra Bloomberg Crude Oil ETF\">UCO</a>, <a href=\"https://seekingalpha.com/symbol/DWTI\" title=\"VelocityShares 3x Inverse Crude Oil ETN\">DWTI</a>, <a href=\"https://seekingalpha.com/symbol/SCO\" title=\"ProShares UltraShort Bloomberg Crude Oil ETF\">SCO</a>, <a href=\"https://seekingalpha.com/symbol/BNO\" title=\"The United States Brent Oil ETF, LP\">BNO</a>, <a href=\"https://seekingalpha.com/symbol/DBO\" title=\"PowerShares DB Oil ETF\">DBO</a>, <a href=\"https://seekingalpha.com/symbol/DTO\" title=\"DB Crude Oil Double Short ETN\">DTO</a>, <a href=\"https://seekingalpha.com/symbol/UGA\" title=\"The United States Gasoline ETF, LP\">UGA</a>, <a href=\"https://seekingalpha.com/symbol/USL\" title=\"The United States 12 Month Oil ETF, LP\">USL</a>, <a href=\"https://seekingalpha.com/symbol/DNO\" title=\"The United States Short Oil ETF, LP\">DNO</a>, <a href=\"https://seekingalpha.com/symbol/OLO\" title=\"DB Crude Oil Long ETN\">OLO</a>, <a href=\"https://seekingalpha.com/symbol/UHN\" title=\"The United States Diesel-Heating Oil ETF, LP\">UHN</a>, <a href=\"https://seekingalpha.com/symbol/SZO\" title=\"DB Crude Oil Short ETN\">SZO</a>, <a href=\"https://seekingalpha.com/symbol/OLEM\" title=\"iPath Pure Beta Crude Oil ETN\">OLEM</a>, <a href=\"https://seekingalpha.com/symbol/OILX\" title=\"Etracs S&amp;P GSCI Crude Oil Total Return Index ETN\">OILX</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210957\" data-linked=\"Goldman slashes oil price outlook\" data-tweet=\"$USO $OIL $UWTI - Goldman slashes oil price outlook https://seekingalpha.com/news/3210957-goldman-slashes-oil-price-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3210957-goldman-slashes-oil-price-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210948\" data-ts=\"1474975366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVM\" target=\"_blank\">CVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210948-fda-places-cel-scis-multikine-study-in-head-and-neck-cancer-on-clinical-hold-shares-off-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA places CEL-SCI&#39;s Multikine study in head and neck cancer on clinical hold; shares off 13% premarket</a></h4><ul> <li>CEL-SCI Corporation (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/CVM\" title=\"Cel-Sci Corporation\">CVM</a>) announces that it has       received verbal notice from the FDA that its <a href=\"http://www.cel-sci.com/cancer_multikine.html\" target=\"_blank\">Multikine</a> (Leukocyte Interleukin Injection) Phase 3 clinical       trial in advanced primary head and neck cancer has been placed on       clinical hold. The company expects to receive a formal letter within 30       days and will work diligently to address the matter. The specific reasons for the hold are not provided. The study currently has about 926 patients enrolled.</li>\n<li>A <a href=\"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=312.42\" target=\"_blank\">full clinical hold</a> means that no new patients can be recruited into the study and all dosing must cease. Patients currently enrolled can continue to be followed.</li>\n<li>The <a href=\"https://clinicaltrials.gov/ct2/show/NCT01265849?term=cel-sci&amp;rank=1\" target=\"_blank\">primary endpoint</a> of the study is overall survival over a three-year period. According to ClinicalTrials.gov, the estimated study completion date is December 2017.</li>          <li>CEL-SCI is also developing its pre-clinical <a href=\"http://www.cel-sci.com/cancer_multikine.html\" target=\"_blank\">L.E.A.P.S.</a> (Ligand Epitope       Antigen Presentation System) technology for the potential treatment of       <a href=\"https://en.wikipedia.org/wiki/Influenza_pandemic\" target=\"_blank\">pandemic influenza</a> in hospitalized patients and as a potential vaccine       for the treatment of rheumatoid arthritis.</li>\n<li>Shares are downÂ <font color=\"red\">13%</font>Â premarket on light volume.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3210948\" data-linked=\"FDA places CEL-SCI&#39;s Multikine study in head and neck cancer on clinical hold; shares off 13% premarket\" data-tweet=\"$CVM - FDA places CEL-SCI&#39;s Multikine study in head and neck cancer on clinical hold; shares off 13% premarket https://seekingalpha.com/news/3210948-fda-places-cel-scis-multikine-study-in-head-and-neck-cancer-on-clinical-hold-shares-off-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3210948-fda-places-cel-scis-multikine-study-in-head-and-neck-cancer-on-clinical-hold-shares-off-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210951\" data-ts=\"1474974479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210951-futures-give-up-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures give up most gains</a></h4><ul>\n<li>S&amp;P 500 futures hadÂ <font color=\"green\">added about 1%Â </font>from the start of last night's debate, but have been slowly leaking since early this morning, and are nowÂ <font color=\"green\">higher by 0.2%</font>. Dow and Nasdaq 100 futures are up the same.</li>\n<li>While Asia closed with modest gains overnight, Europe is adding to yesterday's big losses, with the Stoxx 50<font color=\"red\"> down 0.5%</font>. Deutsche Bank isÂ <font color=\"red\">lower by another 2.8%</font>Â in the premarket and aÂ <font color=\"red\">7% decline</font>Â yesterday.</li>\n<li>The 10-year Treasury yield is flat at 1.576%, gold is off a couple of dollars, and oil isÂ <font color=\"red\">down 1.5%</font>Â to $45.24 per barrel.</li>\n<li>Later this morning, Fed Vice Chair Stanley Fischer will be speaking. Look for more threats to hike rates by year-end.</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>, <a href=\"https://seekingalpha.com/symbol/QQQ\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>, <a href=\"https://seekingalpha.com/symbol/DIA\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>, <a href=\"https://seekingalpha.com/symbol/SH\" title=\"ProShares Short S&amp;P 500 ETF\">SH</a>, <a href=\"https://seekingalpha.com/symbol/SSO\" title=\"ProShares Ultra S&amp;P 500 ETF\">SSO</a>, <a href=\"https://seekingalpha.com/symbol/VOO\" title=\"Vanguard S&amp;P 500 ETF\">VOO</a>, <a href=\"https://seekingalpha.com/symbol/SDS\" title=\"ProShares UltraShort S&amp;P 500 ETF\">SDS</a>, <a href=\"https://seekingalpha.com/symbol/IVV\" title=\"iShares Core S&amp;P 500 ETF\">IVV</a>, <a href=\"https://seekingalpha.com/symbol/SPXU\" title=\"ProShares UltraPro Short S&amp;P 500 ETF\">SPXU</a>, <a href=\"https://seekingalpha.com/symbol/TQQQ\" title=\"ProShares UltraPro QQQ ETF\">TQQQ</a>, <a href=\"https://seekingalpha.com/symbol/UPRO\" title=\"ProShares UltraPro S&amp;P 500 ETF\">UPRO</a>, <a href=\"https://seekingalpha.com/symbol/PSQ\" title=\"ProShares Short QQQ ETF\">PSQ</a>, <a href=\"https://seekingalpha.com/symbol/SPXL\" title=\"Direxion Daily S&amp;P 500 Bull 3x Shares ETF\">SPXL</a>, <a href=\"https://seekingalpha.com/symbol/RSP\" title=\"Guggenheim S&amp;P 500 Equal Weight ETF\">RSP</a>, <a href=\"https://seekingalpha.com/symbol/SPXS\" title=\"Direxion Daily S&amp;P 500 Bear 3x Shares ETF\">SPXS</a>, <a href=\"https://seekingalpha.com/symbol/SQQQ\" title=\"ProShares UltraPro Short QQQ ETF\">SQQQ</a>, <a href=\"https://seekingalpha.com/symbol/QID\" title=\"ProShares UltraShort QQQ ETF\">QID</a>, <a href=\"https://seekingalpha.com/symbol/DOG\" title=\"ProShares Short Dow 30 ETF\">DOG</a>, <a href=\"https://seekingalpha.com/symbol/QLD\" title=\"ProShares Ultra QQQ ETF\">QLD</a>, <a href=\"https://seekingalpha.com/symbol/DXD\" title=\"ProShares UltraShort Dow30 ETF\">DXD</a>, <a href=\"https://seekingalpha.com/symbol/UDOW\" title=\"ProShares UltraPro Dow 30 ETF\">UDOW</a>, <a href=\"https://seekingalpha.com/symbol/RWL\" title=\"RevenueShares Large Cap ETF\">RWL</a>, <a href=\"https://seekingalpha.com/symbol/SDOW\" title=\"ProShares UltraPro Short Dow 30 ETF\">SDOW</a>, <a href=\"https://seekingalpha.com/symbol/VFINX\" title=\"Vanguard 500 Index Fund Inv\">VFINX</a>, <a href=\"https://seekingalpha.com/symbol/EPS\" title=\"WisdomTree Earnings 500 ETF\">EPS</a>, <a href=\"https://seekingalpha.com/symbol/DDM\" title=\"ProShares Ultra Dow 30 ETF\">DDM</a>, <a href=\"https://seekingalpha.com/symbol/QQEW\" title=\"First Trust NASDAQ-100 Equal Weight Index ETF\">QQEW</a>, <a href=\"https://seekingalpha.com/symbol/BXUB\" title=\"Barclays Capital Long B Leveraged Exchange Traded Notes Linked to the S&amp;P 500Â® Total Return Index\">BXUB</a>, <a href=\"https://seekingalpha.com/symbol/QQQE\" title=\"Direxion NASDAQ-100 Equal Weighted Index Shares ETF\">QQQE</a>, <a href=\"https://seekingalpha.com/symbol/SPLX\" title=\"UBS ETRACS Monthly Reset 2xLeveraged S&amp;P 500 total Return ETN\">SPLX</a>, <a href=\"https://seekingalpha.com/symbol/SFLA\" title=\"iPath Long Extended 3x S&amp;P 500 Index TR Index ETN\">SFLA</a>, <a href=\"https://seekingalpha.com/symbol/BXUC\" title=\"Barclays Capital Long C Leveraged Exchange Traded Notes Linked to the S&amp;P 500Â® Total Return Index\">BXUC</a>, <a href=\"https://seekingalpha.com/symbol/QQXT\" title=\"First Trust Nasdaq-100 Ex-Tech Sector Index ETF\">QQXT</a>, <a href=\"https://seekingalpha.com/symbol/SPUU\" title=\"Direxion Daily S&amp;P 500 Bull 2x Shares ETF\">SPUU</a>, <a href=\"https://seekingalpha.com/symbol/SPXE\" title=\"ProShares S&amp;P 500 Ex-Energy ETF\">SPXE</a>, <a href=\"https://seekingalpha.com/symbol/LLSP\" title=\"Direxion Daily S&amp;P 500 Bull 1.25X Shares\">LLSP</a>, <a href=\"https://seekingalpha.com/symbol/UDPIX\" title=\"ProFunds Ultra Dow 30 ProFund Inv\">UDPIX</a>, <a href=\"https://seekingalpha.com/symbol/OTPIX\" title=\"ProFunds NASDAQ-100 Fund Inv\">OTPIX</a>, <a href=\"https://seekingalpha.com/symbol/RYARX\" title=\"Rydex Inverse S&amp;P 500Â® Strategy Fund A\">RYARX</a>, <a href=\"https://seekingalpha.com/symbol/SPXN\" title=\"ProShares S&amp;P 500 Ex-Financial ETF\">SPXN</a>, <a href=\"https://seekingalpha.com/symbol/SPDN\" title=\"Direxion Daily S&amp;P 500 Bear 1x Shares ETF\">SPDN</a>, <a href=\"https://seekingalpha.com/symbol/SPXT\" title=\"ProShares S&amp;P 500 Ex-Technology ETF\">SPXT</a>, <a href=\"https://seekingalpha.com/symbol/SPXV\" title=\"ProShares S&amp;P 500 Ex-Health Care ETF\">SPXV</a>, <a href=\"https://seekingalpha.com/symbol/TALL\" title=\"RBC S&amp;P 500 Trend Allocator Index ETN\">TALL</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210951\" data-linked=\"Futures give up most gains\" data-tweet=\"$SPY $QQQ $DIA - Futures give up most gains https://seekingalpha.com/news/3210951-futures-give-up-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3210951-futures-give-up-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210944\" data-ts=\"1474973661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GI\" target=\"_blank\">GI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210944-boston-scientific-acquires-platform-gi-firm-endochoice-for-8-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boston Scientific acquires platform GI firm EndoChoice for $8 a share</a></h4><ul>\n<li>Thinly traded micro cap <a href=\"http://www.endochoice.com/\" target=\"_blank\">EndoChoice Holdings</a> (NYSE:<a href=\"https://seekingalpha.com/symbol/GI\" title=\"EndoChoice Holdings\">GI</a>) will have great day today. Boston Scientific (NYSE:<a href=\"https://seekingalpha.com/symbol/BSX\" title=\"Boston Scientific Corporation\">BSX</a>) has agreed to acquire the endoscopy devices maker for $8 a share or $210M. Yesterday's close was $4.22.</li>\n<li>The deal should close in Q4.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210944\" data-linked=\"Boston Scientific acquires platform GI firm EndoChoice for $8 a share\" data-tweet=\"$GI $GI $BSX - Boston Scientific acquires platform GI firm EndoChoice for $8 a share https://seekingalpha.com/news/3210944-boston-scientific-acquires-platform-gi-firm-endochoice-for-8-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3210944-boston-scientific-acquires-platform-gi-firm-endochoice-for-8-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":60,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}